Get an email everytime a blog post is made!

Subscribe To This Blog

Like our Book on Facebook!

About Me

Hi! My name is Qadoshyah and I'm the oldest of 11 kids. I live on a ranch in the beautiful country of Northeastern Oklahoma with my family. We are a large household with so many kids that we have various projects going on: We raise goats, pigs, sheep, and rabbits (I raise the rabbits - cute little mini lops) on our 44 acre ranch. Our ranch is also home to bullmastiffs, chickens, guinea hens, ducks, llamas, a donkey, a bottle calf, and several ranch dogs and livestock guardian dogs. The youngest two kids are boy/girl twins born in Feb. '05. The boy happens to have Down syndrome. He is such a blessing to our family :)! Our whole family is also gluten-free, which adds another interesting aspect to our large, active family. We also cook dairy-free & corn-free due to allergies a few kids have. Some of the family is also on the GAPS diet to restore gut health.

Disclaimer

The writers of this blog research and attempt to give what they believe is the most accurate and up-to-date information. Nonetheless, the information on this blog is simply opinions and does not in any way constitute professional legal or medical advice. Also, references or links to external, or third party websites, are provided solely for visitors' convenience and are not controlled nor monitered by us. Links taken to other sites are done so at your own risk.

Moreover, this blog and it's writers do not endorse or support religious views that are not consistent with the Bible. The only faith we have found that is faithful to Scripture can be found at www.atruechurch.info.

Friday, April 10, 2015

Well, it's been awhile since any posting has been done on here. Life changes, to say the least. I recently got married, so the research and blogging about Down syndrome has taken a back burner, to say the least. So, I'll leave this post with some good links for people to contact those who may be more up to date on Down syndrome research, as well as the links as to where to purchase or download the book.

Friday, October 11, 2013

Well, hello, everyone! It's been awhile since I've blogged. Amazing how fast time flies by. Before I knew it, it was October again. What comes with October? Down Syndrome Awareness Month.

For the last few years I've done the 31 for 21 blog challenge - where you blog every day for Down syndrome. This year though, the time snuck up on me and I totally forgot about 31 for 21, until just a few days ago! Sooooo, oh well.

In honor of Down Syndrome Awareness month, I am going to do a special giveaway! One of my website clients runs an online jewelry store called Creative Elements 4 You. She has living life lockets & floating locket charms. I've had the opportunity to photograph many of her items for her website. And, since she heard I had a brother with Down syndrome, she made several custom Trisomy 21/Down Syndrome lockets and jewelry pieces. There's a whole special section on her website for Special Needs now :). Pretty cool!

When I was taking photographs of the T21 jewelry pieces for the website, this one below caught my eye, so I traded her for it. It has 'T21' stamped on one tag and 'Wonderfully made' stamped on the other tag. Perfect!

But, each of the T21 pieces she has are beautiful!

So, I have one of her beautiful lockets here to give away. This giveaway starts NOW and ends October 31, 2013 at 11:59pm. One winner will be chosen, announced on the blog and contacted by email.

There's a few ways to enter the giveaway below. You can enter up to 8 times! After the initial entry below, you will see all 7 bonus entries and can choose to do as few or as many of them as you'd like.

Friday, July 19, 2013

For patients suffering from Down syndrome, the source of their condition can be traced back to just one extra chromosome inherited during development – chromosome 21.

While it is still unclear exactly how this extra copy causes the symptoms of Down syndrome – also known as trisomy 21, its presence in a person’s genetic code is associated with delayed cognitive ability, slowed physical development and a whole host of health conditions, including congenital heart disease, cancer and early on-set Alzheimer’s.

But now, researchers say they have found a way to turn off the extra copy of chromosome 21.

In a new study published online in the journal Nature, scientists from University of Massachusetts Medical School (UMMS) harnessed the abilities of a naturally occurring gene called XIST that acts as an “off switch” in X chromosomes. In a culture of stem cells, the researchers were able to repurpose the XIST gene so that instead of silencing X chromosomes, it silenced the extra chromosome 21 instead.

Though the research only shows proof-of-principle for turning off the chromosome – meaning the method is a long way from being utilized in humans – the findings have huge implications for the future of Down syndrome research. Researchers hope this study will pave the way for a better understanding of the disorder’s pathology and potentially help to create new therapeutic targets for therapies.

“This is the beginning of this idea, and we’re hoping more investigators get interested,” lead researcher Jeanne Lawrence, professor of cell and developmental biology at UMMS, told FoxNews.com. “… We used epigenetics, a new concept, to change the way the DNA is expressed, not changing the DNA itself. This could have a lot of promise in other ways for Down syndrome and other disorders.”

Each human inherits 23 chromosomes from their mother and 23 from their father, equaling 46 chromosomes in each cell. Individuals with Down syndrome inherit three (instead of two) copies of chromosome 21, which ultimately causes their “trisomy 21.”

According to Lawrence, the team’s method for silencing this chromosome was inspired by a naturally occurring process that occurs in women every day.

“What’s important in biology is not that you have the right sequence to your DNA, but you have the right balance of DNA,” Lawrence said. “Women have two X chromosomes and men have one X and Y. Since the Y chromosome lacks a lot of the genes in the X chromosomes, women have more expression of X chromosome genes than men – well that wouldn’t work biologically. So nature had to devise a mechanism to equalize that.”

Lawrence had contributed to a previous study, which had identified that mechanism as the XIST gene, a piece of DNA located in the X chromosome that controls whether or not the chromosome can be silenced. The XIST gene makes a unique non-coding RNA, which accumulates in the nucleus of the cell of the chromosome, triggering changes to the way the chromosome is packaged within the cell. This ultimately renders the chromosome inactive – preventing its DNA from producing proteins and other components.

Hoping to recreate this effect, Lawrence and first author Dr. Jun Jiang, along with UMMS colleague Dr. Lisa Hall, devised a way to insert the XIST gene into the extra chromosome 21 of trisomic cells. In a culture of pluripotent stem cells derived from the skin cells of a Down syndrome patient, the XIST gene was inserted into the chromosomes through the use of zinc finger nuclease (ZFN) technology. The technique ultimately allowed them to cut each chromosome at a specific location in its sequence and then paste the gene into that cut site.

“(Once the gene was inserted), we split the cultures, and took half the cells and turned on the XIST gene to silence the chromosome and (in) the other half we didn’t do that,” Lawrence said. “Then we directly compared how the cell behavior changes…and the neural progenitor cells formed much more quickly in the (cultures) that we had silenced. So you can quickly start to say, ‘What are the pathologies of the different cells and the different organs?’”

According to Lawrence, the success of their findings will ultimately help researchers better understand the different cell pathologies in patients and how the disorder progresses during development. She also noted the more significant implication of their research: that it could ultimately lead to the utilization of chromosome therapies in Down syndrome patients. However, it may be many years before these treatments are realized.

Approximately 6,000 babies with Down syndrome are born each year in the United States, according to the Centers for Disease Control and Prevention. Risk factors for Down syndrome include having a parent with a chromosomal disorder or having a sibling with Down syndrome or another chromosomal disorder. However, the mechanisms behind the condition are still largely unknown. Lawrence hopes that her lab’s findings will help get more people interested in better understanding the disorder.

“Down syndrome hasn’t received as much attention for therapeutics, partly because it’s so complex and there (are) other procedures people use to treat it,” Lawrence said. “Also, people think Down syndrome is going away, but it’s not going away. I think it’s good if this can help draw attention to research (for the disorder).”

Thursday, July 11, 2013

Amazing to see so many people offer to save a child prenatally diagnosed with Down syndrome. If only more families would offer their baby up for adoption, as there are hundreds of families waiting to adopt a baby with DS.

Of course there will be negativity to this also, as I saw one article that was totally hating on the idea of saving a baby with Down syndrome from an abortion. So sickening. Reminds me of this song.

When the Rev. Thomas Vander Woude learned about a young couple planning to abort their unborn baby that had been diagnosed with Down syndrome, the priest reached out and offered a deal: Deliver the child and he would help find an appropriate adoptive family.

But he had to act fast.

The woman, who has not been identified for her privacy and her protection, was just shy of six months pregnant and lives in a state that prohibits abortions past 24 weeks — which meant he had a short time to find a family willing to make a lifelong commitment.

So Father Vander Woude, the lead pastor at Holy Trinity Catholic Church in Gainesville, Va., approached a volunteer who helped manage the church’s social media pages, and she posted an urgent plea on Facebook early Monday morning.

“There is a couple in another state who have contacted an adoption agency looking for a family to adopt their Down Syndrome unborn baby. If a couple has not been found by today they plan to abort the baby. If you are interested in adopting this baby please contact Fr. VW IMMEDIATELY,” the post read. “We are asking all to pray for this baby and the wisdom that this couple realize the importance of human life and do not abort this beautiful gift from God.”

The post asked people to call the church’s office after 9:30 a.m. Monday or to email Father Vander Woude.

No one expected the response they received.

“When we got in and opened up around 9:30, it was nearly nonstop. All day long, we were receiving phone calls from people who wanted to adopt the baby,” church staff member Martha Drennan said. “Father Vander Woude has gotten over 900 emails in regard to the baby.”

The offers were narrowed to three families, which the unborn child’s parents are reviewing with the help of an adoption agency.

Ms. Drennan said the church received phone calls from all over the United States and around the world, including from England, Puerto Rico and the Netherlands.

“I think it is a wonderful use of social media, that word can so quickly get all over the country and even to foreign countries and that the people who see the value of life are stepping up and saying, ‘I will take that baby and raise that baby as mine,’” Ms. Drennan said. “It was a beautiful witness all day long that so many people wanted this child and believed in the dignity of that child — Down syndrome or not.”

The president and founder of the International Down Syndrome Coalition, Diane Grover, stressed the importance of informing couples who are considering abortion for babies with Down syndrome that adoption is a viable option, pointing to the fast and overwhelming response her organization received about this one unborn child as an amazing example.

“When [couples are] in that position, a lot of people wonder if their child [with Down syndrome] would actually get adopted,” Ms. Grover said. “There’s a lot of people waiting, and we are happy to always help.”

David Dufresne, a seminary student who plans to become a priest next year, volunteered to help the overwhelmed church staff take calls.

“I was taking calls for about three hours straight, just talking to people who are willing to adopt this little baby they never knew about until that morning,” Mr. Dufresne said. “I mean, all day long, just receiving phone calls from people who were so generous and within a couple minutes made a life-changing decision. I was really inspired by the goodness of people and what they would do to save a life.”

Tuesday, July 9, 2013

This was posted on the DSTNI listserv by Richard and I thought I'd share here:

Drug Improves
Cognitive Function in Mouse Model of Down Syndrome

July 2, 2013 — An existing FDA-approved drug improves cognitive function in a
mouse model of Down syndrome, according to a new study by researchers at the
Stanford University School of Medicine.

The drug, an asthma medication called formoterol, strengthened nerve
connections in the hippocampus, a brain center used for spatial navigation,
paying attention and forming new memories, the study said. It also improved
contextual learning, in which the brain integrates spatial and sensory
information.

Both hippocampal function and contextual learning, which are impaired in Down
syndrome, depend on the brain having a good supply of the neurotransmitter
norepinephrine. This neurotransmitter sends its signal via several types of
receptors on the neurons, including a group called beta-2 adrenergic receptors.

"This study provides the initial proof-of-concept that targeting beta-2
adrenergic receptors for treatment of cognitive dysfunction in Down syndrome
could be an effective strategy," said Ahmed Salehi, MD, PhD, the study's
senior author and a clinical associate professor of psychiatry and behavioral
sciences. The study will be published online July 2 in Biological Psychiatry.

Down syndrome, which is caused by an extra copy of chromosome 21, results in
both physical and cognitive problems. While many of the physical issues, such
as vulnerability to heart problems, can now be treated, no treatments exist for
poor cognitive function. As a result, children with Down syndrome fall behind
their peers' cognitive development. In addition, adults with Down syndrome
develop Alzheimer's-type pathology in their brains by age 40. Down syndrome
affects about 400,000 people in the United States and 6 million worldwide.

In prior Down syndrome research, scientists have seen deterioration of the
brain center that manufactures norepinephrine in both people with Down syndrome
and its mouse model. Earlier work by Salehi's team found that giving a
norepinephrine precursor could improve cognitive function in a mouse model
genetically engineered to mimic Down syndrome.

The new study refined this work by targeting only one group of receptors that
respond to norepinephrine: the beta-2 adrenergic receptors in the brain. The
researchers began by giving mice a compound that blocks the action of beta-2
adrenergic receptors outside the brain. They then gave the mice formoterol, a
drug that can partially cross the blood-brain barrier and that was already
known to activate beta-2 adrenergic receptors. Because people with Down
syndrome are prone to heart problems, the researchers avoided activating a
different group of norepinephrine-sensitive receptors, the beta-1 adrenergic
receptors, which predominate in the heart.

The scientists saw improvement on a standard test of contextual learning in
mice. In contextual learning, the brain integrates sensory and spatial
information to remember the layout of a complex environment: for instance, a
person using sounds, smells and sights to remember the location of a store in a
shopping mall is using contextual learning. The researchers also saw more
synapses and a more complex structure of dendrites, the nerves' outgoing ends,
in the hippocampus after the affected mice received formoterol.

"The fact that such a short period of giving medication can make these
neurons much more complex is very interesting," Salehi said, noting that
mice in the study received the drug for a maximum of two weeks.

Further tests will be needed to determine whether formoterol might be an
appropriate treatment for people with Down syndrome or whether to use another
drug that activates the same receptors, Salehi said. The dose used in this
study was many times higher than that used for asthma treatment, he cautioned,
so it is not known whether it is safe. A lower dose might work, or other drugs
that affect beta-2 adrenergic receptors might be safer and more effective in
humans. Researchers also want to explore what parts of learning -- taking in
new information, remembering it or both -- are affected by the drug treatment.

Prior research to improve cognitive function in children with Down syndrome has
sometimes raised concerns from families that cognitive treatments would alter
positive attributes of these children's personalities, but Salehi said that is
not the goal of his team's research.

"Our aim is to enable these children to do better in school," Salehi
said. "It is absolutely not to change their personalities or the way they
react to society." Changing a child's personality would be much more complicated
than activating a subgroup of receptors in the brain, he said.Tweet

Tuesday, July 2, 2013

This came across the Einstein-Syndrome listserv last week and I thought I'd share:

On Hatteberg's People, creating a meaningful and enriching life for the
developmentally disabled is the goal of a non-profit company called
Mosaic in Winfield. In a unique relationship, they are partnering with
local businesses to enrich the lives of the Mosaic clients, and the key
is.... coffee.

Monday, July 1, 2013

I've posted a few times about John Marrs, via updates from his mom, Jenny, over the years. John has recently graduated highschool and is now going to a local college. This is the most recent update which his mom shared:

John went into the DMV and took his driver's test
yesterday. In IL a student starts driver's training as a 15 year old. You must
pass the written portion of the IL test before you get your permit to drive
with an adult, which John did. Then, if the driver's ed teacher sees fit, the
student is given a license following his 16th birthday. Our teacher was not our
best friend. So, John had to wait until after he was 18 to test at the DMV. We
finally got around to taking him in yesterday for his driver's test. When he
returned from his drive, I was told, "he is amazing!" John is now a
licensed driver!

Monday, June 24, 2013

Every few months I get a call from someone who either has just received a diagnosis of Down syndrome for their baby or is just finding out about TNI.

Yesterday I received a call from a mother who is just a few months along in her pregnancy and had received a prenatal diagnosis of Down syndrome for her unborn baby. I had a good, long conversation with her about what she can do for her baby.

But, some of the conversation dealt with the diagnosis, since it was still so fresh for her. She was discouraged because of the lack of support she had received and the comments to which people hinted towards abortion. She shared she had always been pro-life, so she was keeping her baby. But, I couldn’t sit here and be quiet over one of the comments she shared. I completely understand why she would be discouraged by the comments she has received.

She shared that one of her co-workers had said, "I'm so sorry! That is one of the worst things that could ever happen to you!"

*sigh*

People need to stop and think about what they are saying. This mother is in the very small percentage – 8% - of families who keep their baby after a prenatal diagnosis of Down syndrome. Yes, that’s right, 92% of babies prenatally diagnosed with Down syndrome have their hearts stopped by abortion and are thrown away as if they are not human.

People act like it’s the end of the world to have a child with Down syndrome. Really, folks, when that child is born, it is just.a.baby. That baby, has eyes, ears, a nose, a mouth, hands, feet, legs, arms, just like you and me. It’s a human. That baby wants to be held and loved by its mother as every other newborn does. That baby needs love and care. It needs its diaper changed. That newborn depends on its mother just like every other baby born does, for love, care, nourishment, protection and its voice. You or I could’ve been born with a third chromosome. That child did not choose to have a third 21st chromosome. God chose to give that child an extra chromosome. It’s time to lighten up, start loving, have compassion on that unborn life, be that baby’s voice and realize that all children are a blessing.

You know what, just because someone might take life a little slower, doesn’t justify ending that baby’s life. It can be a good thing to slow down and appreciate the small things in life more.

Sure, there are health concerns that are associated with Down syndrome. The concern for that is understandable, but does that justify snuffing out that little one’s life? To kill a helpless life that cannot speak for itself? No, it’s time to help that child and be that child’s voice, to protect and care for that baby.

Someone can end that life within their womb because of a diagnosis of a third chromosome. But, it’s not justified, it is wrong and they will be held accountable for their acts. God gave that mother a gift. It’s not a choice. It’s a life. It’s a child. It’s a helpless baby.

I look at my brother and see what a huge blessing he has been from the moment he was born. I cannot even begin to fathom how someone could be so cold to kill (abort) such a helpless life, who had nothing to do with having an extra chromosome. Society has promoted that it’s the “mother’s choice”, but no one seems to remember that there is a baby inside of that womb who is a person. Where is that baby’s choice?

Instead of falling into the 92% of families who abort their babies who are prenatally diagnosed with Down Syndrome, I beg any expectant mothers who run across this blog, to protect that baby who is prenatally diagnosed and be a voice for that baby.

Let's celebrate this baby, who just happens to have a diagnosis of Down syndrome, and sing its birthday song when it's born. Instead of being another birthday song that is unsung, because a child was thrown away, torn up and had its heart stopped. Simply because someone didn’t have the love to care for a child who was a little different.

As I sit here and type through the tears, I realize this post may upset some people, but I will not apologize for speaking up for those babies whose hearts are stopped at the hand of violence, and who suffer for wrong, cloaked in the name of ‘choice.’ I’m not afraid to speak up for the unborn babies who have their bloodshed and are torn up by such a shameful, heartless act. Because it’s not her choice, therefore I will not keep silent.

Introduction: Trisomy 21 or Down Syndrome (DS) patients have a predisposition for Congenital Hypothyroidism which can aggravate their mental status.

Hypothesis: The presence of three copy of Dyrk1a gene, localized in chromosome 21 in Humans, is responsible for a thyroidal dysgenesis.

Our aim is to understand the molecular mechanisms underlying this condition.Methods: The transgenic Dyrk1a (TgDyrk1a) mouse, our DS murine model, contains three copies of the Dyrk1a gene and was obtained through electroporation of a Bacterial Artificial Chromosome containing the entire gene with its own regulatory sequences. We studied their thyroidal phenotype in young adults (8–13 weeks old) by histology, immunohistochemistry and blood T4 hormonal dosages, reflecting the thyroidal function. We compared the thyroidal molecular phenotype of the TgDyrk1a and wild type mice: RNA levels of molecules involved in the thyroidogenesis were studied by qRT-PCR at different embryonic stages.

Results: The average surface of thyroidal follicles in young adult TgDyrk1a mice is smaller (TgDyrk1a: 2164 μm2 versus wild type: 1420 μm2; P=0.005; n=6). They presented also a lower plasmatic T4 (TgDyrk1a: 2.4 ng/ml versus wild type: 3.7 ng/ml; P=0.019; n=14). The overexpression of Dyrk1a in the thyroids leads to an elevation of RNA level expression of Nkx2-1, Foxe1, Thyroperoxidase and Thyroglobulin, involved in thyroidogenesis, at E13.5 and E17.5.Conclusion: Our first results show an abnormal thyroid function and histology in young adult TgDyrk1a mice and an overexpression of thyroidal developmental molecules. To further understand the molecular mechanism linking Dyrk1a overexpression to altered thyroid folliculogenesis and function we are studying some candidates as direct targets of Dyrk1a using thyroidal cell lines.Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.

Funding: This work was supported. Supported by Sandoz SAS, EDF and the Fondation Lejeune. T4 dosage courtesy of Pr S Refetoff, Chicago.

Thursday, June 20, 2013

Remember the study that prompted my big post on EGCG a few months back? The one that showed EGCG can actually create Mitochondrial Biogenesis in individuals with Down syndrome? Yeah, that was huge news!

A critical role for mitochondrial dysfunction has been
proposed in the pathogenesis of Down's syndrome (DS), a human
multifactorial disorder caused by trisomy of chromosome 21, associated
with mental retardation and early neurodegeneration. Previous studies
from our group demonstrated in DS cells a decreased capacity of the
mitochondrial ATP production system and overproduction of reactive
oxygen species (ROS) in mitochondria. In this study we have tested the
potential of epigallocatechin-3-gallate (EGCG) – a natural polyphenol
component of green tea – to counteract the mitochondrial energy deficit
found in DS cells. We found that EGCG, incubated with cultured
lymphoblasts and fibroblasts from DS subjects, rescued mitochondrial
complex I and ATP synthase catalytic activities, restored oxidative
phosphorylation efficiency and counteracted oxidative stress. These
effects were associated with EGCG-induced promotion of PKA activity,
related to increased cellular levels of cAMP and PKA-dependent
phosphorylation of the NDUFS4 subunit of complex I. In addition, EGCG
strongly promoted mitochondrial biogenesis in DS cells, as associated
with increase in Sirt1-dependent PGC-1α deacetylation, NRF-1 and T-FAM
protein levels and mitochondrial DNA content.

In
conclusion, this study shows that EGCG is a promoting effector of
oxidative phosphorylation and mitochondrial biogenesis in DS cells,
acting through modulation of the cAMP/PKA- and sirtuin-dependent
pathways. EGCG treatment promises thus to be a therapeutic approach to
counteract mitochondrial energy deficit and oxidative stress in DS.

Well, we have the full text in PDF format of that study, which is always a helpful resource to have. You can download the PDF here.